These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage. Ando K; Fujita T Clin Exp Nephrol; 2004 Sep; 8(3):178-82. PubMed ID: 15480893 [TBL] [Abstract][Full Text] [Related]
24. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721 [TBL] [Abstract][Full Text] [Related]
25. Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: identification by a novel enzyme immunoassay. Kakutani M; Ueda M; Naruko T; Masaki T; Sawamura T Biochem Biophys Res Commun; 2001 Mar; 282(1):180-5. PubMed ID: 11263989 [TBL] [Abstract][Full Text] [Related]
26. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942 [TBL] [Abstract][Full Text] [Related]
27. Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells. Yoshida T; Koide N; Mori I; Ito H; Yokochi T FEMS Microbiol Lett; 2006 Jul; 260(1):17-22. PubMed ID: 16790013 [TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Minami M; Kume N; Kataoka H; Morimoto M; Hayashida K; Sawamura T; Masaki T; Kita T Biochem Biophys Res Commun; 2000 Jun; 272(2):357-61. PubMed ID: 10833418 [TBL] [Abstract][Full Text] [Related]
29. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Kanata S; Akagi M; Nishimura S; Hayakawa S; Yoshida K; Sawamura T; Munakata H; Hamanishi C Biochem Biophys Res Commun; 2006 Sep; 348(3):1003-10. PubMed ID: 16904074 [TBL] [Abstract][Full Text] [Related]
30. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699 [TBL] [Abstract][Full Text] [Related]
31. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Chen M; Narumiya S; Masaki T; Sawamura T Biochem J; 2001 Apr; 355(Pt 2):289-96. PubMed ID: 11284714 [TBL] [Abstract][Full Text] [Related]
32. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Moriwaki H; Kume N; Sawamura T; Aoyama T; Hoshikawa H; Ochi H; Nishi E; Masaki T; Kita T Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1541-7. PubMed ID: 9763524 [TBL] [Abstract][Full Text] [Related]
33. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay. Chen X; Zhang T; Du G Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435 [TBL] [Abstract][Full Text] [Related]
34. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Kume N; Kita T Curr Opin Lipidol; 2001 Aug; 12(4):419-23. PubMed ID: 11507327 [TBL] [Abstract][Full Text] [Related]
35. Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein. Chen M; Inoue K; Narumiya S; Masaki T; Sawamura T FEBS Lett; 2001 Jun; 499(3):215-9. PubMed ID: 11423119 [TBL] [Abstract][Full Text] [Related]
36. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Yoshida H; Kondratenko N; Green S; Steinberg D; Quehenberger O Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):9-13. PubMed ID: 9693095 [TBL] [Abstract][Full Text] [Related]
37. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Kume N; Kita T Trends Cardiovasc Med; 2001 Jan; 11(1):22-5. PubMed ID: 11413048 [TBL] [Abstract][Full Text] [Related]
38. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Li DY; Chen HJ; Mehta JL Cardiovasc Res; 2001 Oct; 52(1):130-5. PubMed ID: 11557241 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Chen M; Kakutani M; Minami M; Kataoka H; Kume N; Narumiya S; Kita T; Masaki T; Sawamura T Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1107-15. PubMed ID: 10764681 [TBL] [Abstract][Full Text] [Related]
40. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Murase T; Kume N; Kataoka H; Minami M; Sawamura T; Masaki T; Kita T Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):715-20. PubMed ID: 10712396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]